Microbot Medical ( (MBOT)) has issued an announcement. On November 5, 2025, Microbot Medical announced the limited commercial availability of its LIBERTY® Endovascular Robotic System in the U.S. This ...

A magnetic microrobot navigates lung airways, drills microlesions, gathers biomarkers, and rapidly classifies cancer tissue with Raman sensing and machine learning in a single integrated workflow.

We recently published 10 Stocks Losing Big Amid Market Boom. Microbot Medical Inc. (NASDAQ:MBOT) is one of the worst performers on Thursday. Microbot extended its losing streak to a fourth consecutive ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The latest update is out from Microbot ...

Shares of Microbot Medical fell after the company said it would let investors exercise preferred investment options. The stock dropped 18% to $3.34 in morning trading Monday. Despite the decline, ...

The MarketWatch News Department was not involved in the creation of this content. Accelerated Launch Readiness Plans Position Company for Commercialization during Q4 2025 The Company's Initial ...

Microbot Medical has received the FDA’s blessing for its miniature, remote-controlled robot for endovascular procedures, designed to offer clinicians the freedom to sit comfortably and operate outside ...

Microbot Medical has secured FDA clearance for the LIBERTY System, the first FDA-approved, single-use, remotely operated robotic system for peripheral endovascular procedures. With the clearance ...

With its remote endovascular procedure system currently under review at the FDA, Microbot Medical has put forward positive results from a pivotal study touting a 100% satisfaction rate among ...

Shares of Microbot Medical (NASDAQ:MBOT) rose in the premarket on Wednesday after the MedTech firm announced that a pivotal trial for its Liberty endovascular surgical robotic system reached the ...